COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
OSE Immunotherapeutics Propose une Evolution de sa Gouvernance et Réaffirme ses Priorités Stratégiques à l’Approche de son Assemblée Générale Annuelle
OSE Immunotherapeutics propose une évolution de sa gouvernance et réaffirme ses priorités stratégiques. Assemblée Générale Annuelle le 30 septembre 2025 à Paris -
-
COMMUNIQUÉ DE PRESSE
OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General Meeting
OSE Immunotherapeutics announces proposed governance evolution and reaffirms strategic priorities ahead of Annual General Meeting. Company focuses on Tedopi® and Lusvertikimab to unlock full potential -
COMMUNIQUÉ DE PRESSE
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Valneva SE announces FDA's suspension of IXCHIQ® chikungunya vaccine license in the U.S. due to serious adverse events, despite reported cases consistent with clinical trials. Sales impact to be evaluated -
COMMUNIQUÉ DE PRESSE
Daldrup & Söhne AG awarded contract as general contractor for deep geothermal doublet near Munich
Daldrup & Söhne AG awarded EUR 16.8 million contract for geothermal project near Munich by Amperland Thermalwärme GmbH, supported by BEW program. Company specializes in drilling and geothermal energy -
